Assessment of antidiabetogenic potential of fermented soybean extracts in streptozotocin-induced diabetic rat

Food and Chemical Toxicology

Volumn 50, Issue 11, 2012, Pages 3941-3948

  Lim, Kyu Hee ^a   Han, Ji Hui ^a   Lee, Jae Yeon ^b   Park, Young Shik ^b   Cho, Yong Seok ^b,c   Kang, Kyung Don ^b   Yuk, Won Jeong ^b   Hwang, Kyo Yeol ^b   Seong, Su Il ^b,c   Kim, Bumseok ^a   Kwon, JungKee ^a   Kang, Chang Won ^a   Kim, Jong Hoon ^a  

^a Chonbuk National University   (South Korea)

^b R and D Center for Life Science   (South Korea)

^c Suwon University   (South Korea)

Author keywords

Diabetes mellitus; Fermented soybean extracts; Oxidative stress; Streptozotocin; Vascular responsiveness

Indexed keywords

ANTIDIABETIC AGENT; BTD 1; CARBACHOL; CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE 3; INSULIN; MALONALDEHYDE; NORADRENALIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTERY ENDOTHELIUM; ARTICLE; BACILLUS SUBTILIS; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; FERMENTATION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SOYBEAN; STREPTOZOCIN DIABETES; THORACIC AORTA; TREATMENT DURATION;

ANIMALS; ANTIOXIDANTS; AORTA; BACILLUS SUBTILIS; BLOOD GLUCOSE; BODY WEIGHT; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; FERMENTATION; GLUTATHIONE PEROXIDASE; HYPOGLYCEMIC AGENTS; MALE; MALONDIALDEHYDE; NOREPINEPHRINE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SOYBEANS; STREPTOZOCIN; SUPEROXIDE DISMUTASE; VASODILATOR AGENTS;

BACILLUS SUBTILIS; GLYCINE MAX; RATTUS;

EID: 84866159528     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.08.036     Document Type: Article

References (48)

1. 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J. Cardiovas. Pharmacol. 1990, 16:239-248.
2. Adeghate E., Parvez S.H. Nitric oxide and neuronal and pancreatic beta cell death. Toxicology 2000, 153:143-156.
3. Alain D.B. Postprandial hyperglycaemia and α-glucosidase inhibitors. Diabetes Res. Clin. Pract. 1998, 40:51-55.
4. Asano N., Yamashita T., Yasuda K., Ikeda K., Kizu H., Kameda Y., Kato A., Nash R.J., Lee H.S., Ryu K.S. Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.). J. Agric. Food Chem. 2001, 49:4208-4213.
5. Atkin S.H., Dasmahapatra A., Jaker M.A., Chorost M.I., Reddy S. Fingerstick glucose determination in shock. Annu. Int. Med. 1991, 114:1020-1024.
6. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999, 48:1-9.
7. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1992, 40:405-412.
8. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000, 49:27-29.
9. Chen V., Ianuzzo C.D. Dosage effect of streptozotocin on rat tissue enzyme activities and glycogen concentration. Can. J. Physiol. Pharmacol. 1982, 60:1251-1256.
10. Ezure Y., Marue S., Miyazaki K., Kawamata M. Moranoline(1-deoxynojirimycin) fermentation and its improvement. Agric. Biol. Chem. 1985, 49:1119-1125.
11. Fairbanks V., Klee G.G. Biochemical Aspects of Haematology, Tietz Textbook of Clinical Chemistry 1994, Saunders WB, Philadelphia.
12. Floris A.V., Peter L.L., Reinier P.A., Eloy H.V., Guy E.R., Chris V.W. α-Glucosidase inhibitors for patients with type 2 diabetes. Diabetic Care 2005, 28:154-162.
13. Frandsen T.P., Svensson B. Plant α-glucosidases of glycoside hydrolase family 31. Molecular properties, substrate specificity, reaction mechanism, and comparison with family members of different origin. Plant Mol. Biol. 1998, 37:1-13.
14. Georg P., Ludvik B. Lipids and diabetes. J. Clin. Basic Cardiol. 2000, 3:159-162.
15. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19:257-267.
16. Holman R.R. Assessing the potential for α-glucosidase inhibitors in prediabetic states. Diabetes Res. Clin. Pract. 1998, 40:21-25.
17. Jin L., Xue H.Y., Jin L.J., Li S.Y., Xu Y.P. Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 2008, 582:162-167.
18. Karasu C., Altan V.M. The role of endothelial cells on the alterations in vascular reactivity induced by insulin-dependent diabetes mellitus: effects of insulin treatment. Gen. Pharmacol. 1993, 24:743-755.
19. Kim H.B., Lee H.S., Kim S.J., Yoo H.J., Hwang J.S., Chen G., Young H.J. Ethanol extract of fermented soybean, Chungkookjang, inhibits the apoptosis of mouse spleen, and thymus cells. J. Microbiol. 2007, 45(3):256-261.
20. Kim, H.J., Chae, I.G., Lee, S.G., Jeong, H.J., 2010. Effects of fermented red ginseng extracts on hyperglycemia in streptozotocin-induced diabetic rats. In: Eun-Ju Lee, E.J., Lee, I.S. (Eds.), J. Ginseng Res. 34, 104-112.
21. Kim H.S., Lee J.Y., Hwang K.Y., Cho Y.S., Park Y.S., Kang K.D., Seong S.I. Isolation and identification of a Bacillus sp. Producing α-glucosidase inhibitor 1-deoxynojirimycin. Kor. J. Microbiol. Biotechnol. 2011, 39:49-55.
22. 1-induced hepatotoxicity in rat. J. Ginseng Res. 2011, 35(2):243-249.
23. Kim H.J., Lee S.G., Chae I.G., Kim M.J., Im N.K., Yu M.H., Lee E.J., Lee I.S. Antioxidant effects of fermented red ginseng extracts in streptozotocin-induced diabetic rats. J. Ginseng Res. 2011, 35(2):129-137.
24. Ko C.N., Park S.U., Chang G.T., Jung W.S., Moon S.K., Park J.M., Cho K.H. Antihyperlipidemic and antioxidant effects of the mixture of ginseng radix and Crataegi Fructus: experimental study and preliminary clinical results. J. Ginseng Res. 2011, 35(2):162-169.
25. Laybutt D.R., Kaneto H., Hasenkamp W., Grey S., Jonas J.C., Sgroi D.C., Groff A., Ferran C., Bonner-Weir S., Sharma A., Weir G.C. Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia. Diabetes 2002, 51:413-423.
26. Liu Z., Li J., Zeng Z., Liu M., Wang M. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats. Chem. Biol. Interact. 2008, 173:68-75.
27. Macleod K.M., McNeill J.H. Alpha adrenoceptor mediated responses in aorta from three month streptozotocin diabetic rats. Proc. West. Pharmacol. 1982, 25:245-247.
28. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 2003, 17:24-38.
29. Mauer M., Fioretto P., Woredekal Y. Diabetic nephropathy. Diseases of the Kidney 2001, Lippincott Williams, Wilkins, Philadelphia. seventh ed. E.A. Friedman, R.W. Schrier (Eds.).
30. Meghana K., Sanjeev G., Ramesh B. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. Eur. J. Pharmacol. 2007, 577:183-191.
31. Miyahara C., Miyazawa M., Satoh S., Sakai A., Mizusaki S. Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J. Nutr. Sci. Vitaminol. 2004, 50:161-164.
32. Murao S., Miyata S. Isolation and characterization of a new trehalase inhibitor S-GI. Agric. Biol. Chem. 1980, 44:219-221.
33. Niehaus W.G., Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur. J. Biochem. 1968, 6:126-130.
34. Soh J., Kwon D.Y., Cha Y.S. Hepatic gene expression profiles are altered by dietary unsalted korean fermented soybean (chongkukjang) consumption in mice with diet-induced obesity. J. Nutr. Metab. 2011, 2011:260214.
35. Szkudelski T. The mechanism of alloxan and streptozotocin action in β-cells of the rat pancreas. Physiol. Res. 2001, 50:537-546.
36. Ozcelikay A.T., Pekiner C., Ari N., Ozturk Y., Ozuari A., Altan V.M. The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats. Diabetologia 1994, 37:572-578.
37. Park Y.M., Sohn C.M., Jang H.C. A study on status and subjective recognition of functional foods among diabetic patients. J. Kor. Diet. Assoc. 2005, 11:216-222.
38. Potenza M.A., Gagliardi S., Nacci C., Carratu M.R., Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr. Med. Chem. 2009, 16:94-112.
39. Romaniouk A.V., Silva A., Feng J., Vijay I.K. Synthesis of a novel photoaffinity derivative of 1-deoxynojirimycin for active site-directed labeling of glucosidase I. Glycobiology 2004, 14:301-310.
40. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B. Selenium: biochemical roles as a component of glutathione peroxidase. Science 1973, 179:588-590.
41. Schmidt D.D., Frommer W., Müller L., Truscheit E. Glucosidase inhibitiors from Bacilli. Naturwissenschaften 1979, 66:584-585.
42. Senses V., Ozyazgan S., Ince E., Tuncdemir M., Kaya F., Ozturk M., Sultuybek G., Akkan A.G. Effect of 5-aminoimidazole-4-carboxamide riboside (AICA-r) on isolated thoracic aorta responses in streptozotocin-diabetic rats. J. Basic Clin. Physiol. Pharmacol. 2001, 12:227-248.
43. Sekar N., Kanthasamy S., William S., Subramanian S., Govindasamy S. Insulinic actions of vanadate in diabetic rats. Pharmacol. Res. 1990, 22:207-217.
44. Singab A.N., El-Beshbishy H.A., Yonekawa M., Nomura T., Fukai T. Hypoglycemic effect of Egyptian Morus alba root bark extract: effect on diabetes and lipid peroxidation of streptozotocin-induced diabetic rats. J. Ethnopharmacol. 2005, 14:333-338.
45. Soto C., Recoba R., Barron H., Alvarez C., Favari L. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp. Biochem. Physiol. 2003, 136:205-212.
46. Stein D.C., Kopec L.K., Yasbin R.E., Young F.E. Characterization of bacillus subtilis DSM704 and its production of 1-deoxynojirimycin. Appl. Environ. Microbiol. 1984, 8:280-284.
47. Yalow R.S., Berson S.A. Immunoassay of plasma insulin in man. Diabetes 1961, 10:339.
48. Yin H., Miao J., Zhang Y. Protective effect of β-casomorphin-7 on type 1 diabetes rats induced with streptozotocin. Peptides 2010, 31:1725-1729.